BioSpace News Archive

Business

Coya Therapeutics (“Coya”) Announces the Appointment of Dr. Merit Cudkowicz, M.D., M.Sc., as Clinical Advisor to Support the Development of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, today announced the engagement of Merit Cudkowicz, MD, MSc as expert clinical advisor.

July 19, 2023
·
8 min read
Business

Riparian Pharmaceuticals Announces Agreements with Pfizer for Novel Cardiovascular Programs

Riparian Pharmaceuticals today announced it has entered into an exclusive license agreement and research agreement with Pfizer.

July 19, 2023
·
1 min read
Business

OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FIND

OpGen, Inc. reported today that its German subsidiary Curetis GmbH has met all milestones under its extended and expanded research and development (“R&D”) collaboration agreement with FIND.

July 19, 2023
·
5 min read
Genetown

Akebia Therapeutics to Present at the H.C. Wainwright Kidney Conference

Akebia Therapeutics, Inc. today announced that John Butler , Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 2nd Annual Kidney Conference, which will take place as a virtual event on Tuesday, July 25, 2023.

July 19, 2023
·
1 min read
Drug Development

Emergex Reports Promising Data from Completed Swiss Phase I Trial of CoronaTcP™, T Cell-Priming Immune Set-Point Candidate for Betacoronaviruses

Emergex Vaccines Holding Limited today announced the successful completion of naNO-COVID, a Phase I clinical trial in Switzerland investigating the safety and reactogenicity of CoronaTcP™1 in healthy volunteers.

July 19, 2023
·
5 min read
Drug Development

Faron Updates Positive Clinical Data from Phase I/II BEXMAB Study of Bexmarilimab in Relapsed/Refractory AML and MDS BEXMAB Study Update

Faron Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, announces new positive clinical data from the Company’s ongoing Phase I/II BEXMAB study.

July 19, 2023
·
7 min read
Business

Telix Reports Continued Double-Digit Revenue Growth and Positive Operating Cash Flow

Telix Pharmaceuticals Limited issues its Appendix 4C quarterly cash flow report and accompanying Activities Report for the quarter ended 30 June 2023.

July 19, 2023
·
17 min read
Drug Development

ELGAN Pharma Awarded $2.5 Million EU Grant to Support Phase III Registrational Study of ELGN-GI for the Treatment of Intestinal Malabsorption in Preterm Infants

Elgan Pharma announced that it has been awarded by the European Innovation Council a grant of €2.36 million in a highly competitive selection process.

July 19, 2023
·
3 min read
Business

BioCryst Selects Er-Kim Pharmaceuticals as Commercial Partner for ORLADEYO® (berotralstat) in Turkey

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the company has entered into a collaboration with Er-Kim Pharmaceuticals to commercialize ORLADEYO ® (berotralstat) in Turkey.

July 19, 2023
·
6 min read
Business

New Sericulture Experts Join Kraig Biocraft Laboratories, Bringing Extensive Experience Supporting Acceleration of Production Ramp-Up

Kraig Biocraft Laboratories, Inc. announces today that it has filled two key researcher positions.

July 19, 2023
·
3 min read